Articulate Labs

What Articulate Labs does

Articulate Labs is a private health technology company headquartered in Dallas, Texas, founded in 2012, that develops KneeStim™, the first commercially described gait-synchronous neuromuscular electrical stimulation (NMES) system intended for knee rehabilitation. The wearable device uses embedded motion sensors and an adaptive algorithm to deliver electrical stimulation synchronized with the user's walking pattern, activating therapy automatically during ambulation rather than requiring scheduled sessions or manual controls. The product is positioned for patients recovering from knee surgery, sports injuries, and neurological conditions, with clinician-facing software providing adherence tracking and gait-quality data.

The company operates a dual go-to-market combining enterprise field sales to clinicians and health systems (demo-driven, with RTM billing pathway documentation and a clinician dashboard) and direct-to-consumer sales through its own website processed via Lemonsqueezy. Revenue mechanics center on hardware sales of the KneeStim device, supplemented by recurring service value through Remote Therapeutic Monitoring (RTM) billing under CPT codes 98975-98977 and a web-based clinician dashboard that captures objective movement data. Customer segments named across the source material include individual patients, physical therapy clinics, home health providers, rural health systems, and military rehabilitation programs, supported by a content-marketing-heavy website and demo-driven sales motion.

Articulate Labs is led by founders Josh Rabinowitz (CEO) and Herbie Kirn (CSO) and has remained a lean organization with 1-10 employees. Capital formation has been routed through accelerator and competition paths rather than traditional institutional venture rounds — Health Wildcatters (2017, $570K), MassChallenge (2020, twice), Techstars (2022, $120K), and mHUB (2024) — with cumulative disclosed funding of approximately $715,000, implying a capital-efficient, bootstrapped commercial trajectory. The website's 2025 copyright combined with a disclaimer that "statements have not yet been evaluated by the Food and Drug Administration" indicates an actively operating but pre-FDA-clearance commercial posture.

Name

Articulate Labs

Legal name

Articulate Labs

Website

https://articulatelabs.tech

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Articulate Labs (Dallas, TX) develops KneeStim™, a gait-synchronous neuromuscular electrical stimulation wearable for knee rehabilitation that adapts to users' walking patterns in real time. It serves patients, physical therapy clinics, home health and rural health providers, and military rehabilitation programs.

Ownership category

akta.pro rank

Product category

Wearable Rehabilitation Medical Devices

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

Keywords

• Wearable rehabilitation devices
• Neuromuscular electrical stimulation
• Gait-synchronous therapy
• Remote therapeutic monitoring
• Knee recovery technology

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Device/Hardware Sales: KneeStim is a wearable medical device sold to patients and healthcare providers. The hardware device forms the primary revenue base, with ongoing revenue potentially from software/subscription components for remote monitoring and data dashboards.
2. RTM Monitoring Services: Remote Therapeutic Monitoring (RTM) billing through CPT codes 98975-98977 provides recurring revenue streams for clinician monitoring activities. Web-based dashboards and data services support ongoing subscription-style revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Articulate Labs designs, manufactures, and sells KneeStim, a wearable neuromuscular electrical stimulation (NMES) device that automatically delivers therapeutic muscle stimulation in synchrony with a user's real-time walking pattern, turning everyday movement into rehabilitation. The system combines proprietary hardware, embedded motion sensors, and an adaptive learning algorithm, and is paired with a web-based clinician dashboard that supports Remote Therapeutic Monitoring (RTM) billing under CPT codes 98975–98977. The company sells KneeStim directly to patients through its website and to clinicians, physical therapy clinics, home health agencies, rural health systems, and military rehabilitation programs via enterprise field sales.

Product overview

Articulate Labs offers a single unified product, KneeStim™, a gait-synchronous neuromuscular electrical stimulation (NMES) device designed for knee rehabilitation. The system represents the first and only gait-synchronous health technology that delivers personalized, adaptive therapy automatically during the user's daily walking activities, eliminating the need for scheduled therapy sessions or manual controls.

Differentiator

Problem solved

Functional benefit

Brands

• KNEESTIM™: Gait-synchronous neuromuscular electrical stimulation (NMES) system for rehabilitation and recovery. The first and only gait-synchronous health technology that delivers automatic, adaptive therapy during walking and daily movement activities.

Products and services

• KneeStim

Quantifiable outcome

• 68% improvement in patient adherence compared to traditional home exercise programs
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Restorative Therapies: Restorative Therapies produces functional electrical stimulation (FES) systems for rehabilitation, including therapy bikes and integrated stimulation platforms—overlapping with Articulate Labs' rehabilitation neurostimulation focus.
• NeuroMetrix: NeuroMetrix builds wearable neurostimulation devices for chronic pain and rehabilitation, making it a direct competitor in the digital/wearable NMES category targeting clinicians and patients.
• Compex: Compex (now under DJO/Enovis) is a well-known NMES brand used by physical therapists, athletes, and patients for muscle activation and rehabilitation—closely comparable in modality to KneeStim.
• Zynex Medical: Zynex manufactures and distributes NMES and TENS devices used in rehabilitation and pain management, sharing the same core modality and clinician-reimbursement channels as KneeStim.
• Bioness: Bioness develops functional electrical stimulation and rehabilitation medical devices (including knee and gait-related systems), directly competing with Articulate Labs in the wearable neurostimulation category for rehabilitation.
• RS Medical: RS Medical manufactures and rents NMES and rehabilitation devices prescribed through physical therapy clinics, competing with KneeStim for the same clinician-prescribed home-use channel.
• BioMedical Life Systems: BioMedical Life Systems is an established NMES/TENS manufacturer serving physical therapy and rehabilitation markets, providing direct product-category competition to KneeStim.

Broad incumbents

• VQ OrthoCare: VQ OrthoCare supplies orthopedic and rehabilitation products to clinicians, offering a broader knee and rehab portfolio that includes devices competing with KneeStim's use case.
• DJO / Enovis: DJO (now part of Enovis) is a broad orthopedic and rehabilitation portfolio company offering NMES, bracing, and recovery products across many categories—a large incumbent that competes broadly with Articulate Labs in rehab clinics.

Emerging players

• Axiobionics: Axiobionics develops wearable rehabilitation and functional stimulation technology, intersecting with Articulate Labs in the wearable neuro-rehabilitation niche but with a smaller commercial footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/articulatelabs
• LinkedInlinkedin.com/company/articulate-labs

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Articulate Labs